Published in Am J Health Syst Pharm on December 01, 1995
Pharmacists' knowledge and attitudes toward herbal medicine. Ann Pharmacother (2000) 1.80
Perceptions of pharmacists about adverse effects of corticosteroid therapy: focus on osteoporosis. J Am Pharm Assoc (Wash) (1999) 1.39
Budesonide inhalation powder: a review of its pharmacologic properties and role in the treatment of asthma. Pharmacotherapy (1998) 1.39
The role of academia in community-based pharmaceutical care. Pharmacotherapy (1998) 1.07
A comprehensive investigation of inpatient intravenous colchicine use shows more education is needed. J Rheumatol (1996) 0.97
Phenytoin-induced hyperglycemia. Am J Hosp Pharm (1981) 0.94
HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis. J Rheumatol (1999) 0.92
Liver function assessment by drug metabolism. Pharmacotherapy (1990) 0.87
Effect of sucralfate on ibuprofen absorption in normal volunteers. Clin Pharm (1985) 0.85
Effect of antacid suspension on the pharmacokinetics of ibuprofen. Clin Pharm (1987) 0.83
Monitoring digoxin therapy in two long-term facilities. J Am Geriatr Soc (1981) 0.80
Effect of cimetidine on quinidine clearance. Ther Drug Monit (1984) 0.79
Home blood glucose monitoring. Ann Pharmacother (1999) 0.79
Effect of ranitidine and cimetidine on ibuprofen pharmacokinetics. Clin Pharm (1988) 0.79
The impact of disease management on outcomes and cost of care: a study of low-income asthma patients. Inquiry (2000) 0.79
Economics of antihypertensive therapy in the elderly. Drugs Aging (2001) 0.79
The effect of flurbiprofen on steady-state plasma lithium levels. Pharmacotherapy (1997) 0.78
B lymphocytic clonal expansion in rheumatoid arthritis. J Rheumatol (1996) 0.77
Effect of ibuprofen on lithium plasma and red blood cell concentrations. Clin Pharm (1986) 0.77
Effects of three antacids on the bioavailability of valproic acid. Clin Pharm (1983) 0.77
Implementing disease management in community pharmacy practice. Clin Ther (1998) 0.76
Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty. J Rheumatol (1998) 0.75
Migraine: a comprehensive review of new treatment options. Pharmacotherapy (1999) 0.75
Cyclosporine dosing for RA. Am Pharm (1995) 0.75
Improving ambulatory management of asthmatic patients. Am J Med (1997) 0.75
Effects of cimetidine or ranitidine on the pharmacokinetics of flurbiprofen. Clin Pharm (1986) 0.75
Possible diclofenac-quinolone interaction. Clin Pharm (1989) 0.75
Effect of acute and chronic terfenadine on free and total serum phenytoin concentrations in epileptic patients. Epilepsia (1989) 0.75
Cephalosporin antibiotic interference with theophylline assay. Clin Pharm (1983) 0.75
Is methotrexate interaction critical? Am Pharm (1994) 0.75
Influence of racial differences on effects of ranitidine and cimetidine on ibuprofen pharmacokinetics. Clin Pharm (1989) 0.75
Hearing or sight defects and drug use in the elderly. Am J Hosp Pharm (1985) 0.75
Administering IV nitroglycerin: nursing implications. Dimens Crit Care Nurs (1983) 0.75
Selection of peak flowmeters in ambulatory asthma patients: a review of the literature. Chest (1998) 0.75
Alpha-methyldopa interference with the phosphotungstate uric acid test. Am J Hosp Pharm (1976) 0.75
A review of Lyme disease: its prevention and treatment. Am Pharm (1991) 0.75
Current options for the treatment of systemic scleroderma. Clin Pharm (1991) 0.75
Spacer inhalers. Arch Intern Med (1986) 0.75
Tumor necrosis factor microsatellite markers TNFa5b5 and TNFa6b5 influence adverse reactions to parenteral gold in Caucasians. J Rheumatol (1999) 0.75
Steady-state salicylate plasma and urinary metabolite concentrations from plain, buffered, or enteric-coated aspirin. Clin Pharm (1983) 0.75